rfxcel Awarded ISO 9001:2015 Certification
rfxcel, the leader in track and trace solutions for global supply chains announced that it is now ISO 9001:2015 certified for Quality Management Systems.
The certifying organization used by rfxcel examined rfxcel’s commitment to customer service and requests, commitment to quality from upper management, and processes and procedures put in place to ensure the delivery of quality systems. rfxcel demonstrated its long-standing commitment to quality management and processes and was officially certified on November 4, 2018.
“This certification is a testament to rfxcel’s determination and commitment to continually improve as a business, provide our customers with uncompromising experiences, and drive a culture that produces high-quality products and services. Attaining this certification indicates the dedication rfxcel has taken in supporting our customers and exceeding their expectations. Quality is one of our strengths, and it is the reason we are the preferred partner for organizations globally.” – Amit Sewak, rfxcel, Director of Quality Management & Validation.
The scope of the certification included rfxcel’s flagship product rfxcel Traceability System for serialization (rTS). rTS is used by some of the world’s largest pharmaceutical manufacturers, wholesalers, distributors, and dispensers and is being adopted in other industries like Food and Beverage, Consumer Goods, and the Public Sector.
According to ISO, the 9001:2015 certification means that rfxcel demonstrated the seven following quality management principles for rTS:
• QMP 1 Customer Focus
• QMP 2 Leadership
• QMP 3 Engagement of People
• QMP 4 Process Approach
• QMP 5 Continual Improvement
• QMP 6 Evidence-Based Decision Making
• QMP 7 Relationship Management
“Very few if any of our competitors can claim to be ISO 9001:2015 certified. It is a testament to our role as a leader in our industry and our commitment to quality. This certification assures our customers that quality management practices are baked into our systems. Those quality practices and procedures are passed on to our customers through consistent products and services, which brings business benefits like a lower total cost of ownership and predictable outcomes.” – rfxcel, CEO Glenn Abood
Related News
-
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. -
News Amgen sues Samsung biologics unit over biosimilar for bone disease
Samsung Bioepis, the biologics unit of Samsung, has been issued a lawsuit brought forth by Amgen over proposed biosimilars of Amgen’s bone drugs Prolia and Xgeva. -
News CPHI Podcast Series: Why we need to consider women in clinical trials
The latest episode of the CPHI Podcast Series with Lucy Chard covers women's health, specifically women's representation in clinical trials, the associated bias, and the impacts on health for this population. -
News US FDA does not approve MDMA therapy for PTSD, requests more data
The MDMA-based therapeutic developed by Lykos Therapeutics, a California-based Public Benefit Corporation (PBC), has been reviewed and unapproved by the US FDA. The regulator has requested additional phase III trial data for further safety and efficacy... -
News Novartis and Viatris latest facing lawsuit over HeLa cell misuse
Global pharmaceutical companies Novartis and Viatris are the latest hit with a lawsuit claim pertaining to alleged misuse of the ‘HeLa’ cell line from the estate of woman whose cancerous tissue cells were taken without consent. -
News Sanofi invests billions into Frankfurt insulin production site
French pharmaceutical company Sanofi have announced an investment of EUR1.3 billion at their existing BioCampus site in Frankfurt am Main for the expansion of insulin production. -
News Novel oral Type 1 diabetes drug gains US FDA IND designation
A University of Alabama at Birmingham startup has gained FDA clearance for Investigational New Drug clinical trials for an oral Type 1 diabetes drug, a milestone for diabetes treatment. -
News A Day in the Life of a Vice President in R&D & Engineering
In the Day in the Life of Series, we've already had the chance to get to know a range of people in various roles in the pharma industry. In the latest interview we get a glimpse into the R&D side of things from Jennifer Sorrells, Vice Presiden...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance